First & Only in Southwest Louisiana


Only group to perform implant the Cardio MEMS system.

 The CardioMEMS™ HF System is the first and only FDA-approved heart failure (HF) monitoring system proven to significantly reduce HF hospital admissions and improve quality of life in NYHA class III patients.

Only group to have a successful CT ER triage program and utilize non-invasive FFRCT.

 Only group to have a successful CT ER Triage program and utilize non-invasive FFRCT.

Only group to perform a Transcatheter Mitral Valve Replacement.

 For people who cannot undergo surgery, Transcatheter Mitral Valve Repair provides a newer, minimally invasive option for treating the most common form of mitral valve leakage.

Only group to have a free standing outpatient cath lab.

  An outpatient cardiology center to provide diagnostic imaging and catheterizations.

Only group to treat pulmonary emboli with EKOS device.

 The purpose of the EKOS EndoWave Infusion Catheter System is to enhance catheter-directed thrombolysis by accelerating the fibrinolytic process with the application of ultrasound. Improving the efficiency of the thrombolytic process reduces the treatment time and total lytic dose delivered, thereby lowering the overall cost of therapy and the risk of an associated bleeding complication.

Only group to implant the Watchman device for stroke prevention in Afib patients.

 Othe Watchman device is a small implant placed in to the heart that can reduce the risk of stroke in patients with atrial fibrillation. Afib patients are at increased risk of stroke, mainly due to clots that form in a small chamber of the heart known as the left atrial appendage. 

Only facility to have Cardiac PET imaging.

 A PET scan of the heart is a noninvasive nuclear imaging test.

Only group to use Optical Coherence Tomography.

 Optical coherence tomography (OCT) is an emerging technology for performing high-resolution cross-sectional imaging. OCT is analogous to ultrasound imaging, except that it uses light instead of sound.

Only group to have a comprehensive vein practice.

 Experienced in treating patients with all kinds of venous disease, ranging from blood clots, to more severe problems such as vascular malformations.


First group to perform TAVR (Transcatheter Aortic Valve Implantation).

 This minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve’s place.

First group to perform leadless pacemaker implants.

 A leadless pacemaker is a small implantable device that sends electrical pulses to the heart whenever it senses that the heartbeat is too slow. Leadless pacing devices are placed directly in the heart without the need for a surgical pocket and insulated wires (called leads).

First group to have a carotid stent program.

 Carotid artery stenting (CAS) has emerged as a highly promising therapy for treatment of carotid artery stenosis.

First group to implant Subcutaneous Implantable Defibrillator (SICD) devices.

 Subcutaneous implantable defibrillators are used to treat patients who have experienced or are at risk for life-threatening heart arrhythmias. These devices monitor the heartbeat and automatically deliver a small electrical shock to the heart to convert a potentially lethal rhythm into one that sustains life.

First group to perform and interpret Cardiac CT Angiography in outpatient and ER patients.

 Computed tomography angiography (CTA) is a noninvasive heart imaging test currently undergoing rapid development and advancement. High-resolution, 3-dimensional pictures of the moving heart and great vessels are produced during a coronary CTA to determine if either fatty or calcium deposits (plaques) have built up in the coronary arteries.

First group to use percutaneous left ventricular assist devices.

 This device assist the heart by helping the ventricles pump blood, easing the workload of the heart in patients with heart failure.

First and Only in Southwest Louisiana
Services and Procedures
Patient Forms